Share on StockTwits

Sucampo Pharmaceuticals (NASDAQ:SCMP) issued its quarterly earnings data on Wednesday. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.10, Stock Ratings Network reports. The company had revenue of $24.50 million for the quarter, compared to the consensus estimate of $22.75 million. During the same quarter in the previous year, the company posted $0.32 earnings per share. The company’s revenue for the quarter was down 29.8% on a year-over-year basis.

Sucampo Pharmaceuticals (NASDAQ:SCMP) traded up 1.82% during mid-day trading on Wednesday, hitting $8.39. The stock had a trading volume of 222,732 shares. Sucampo Pharmaceuticals has a 1-year low of $4.55 and a 1-year high of $11.00. The stock has a 50-day moving average of $8.93 and a 200-day moving average of $7.34. The company has a market cap of $351.2 million and a P/E ratio of 19.43.

Sucampo Pharmaceuticals, Inc is a pharmaceutical Company. The Company is focused on the discovery, development and commercialization of drugs based on prostones.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.